Related Experiment Video

Updated: Dec 8, 2025

Lipidomics and Transcriptomics in Neurological Diseases
09:58

Lipidomics and Transcriptomics in Neurological Diseases

Published on: March 18, 2022

3.8K

Novel Approaches for Omega-3 Fatty Acid Therapeutics: Chronic Versus Acute Administration to Protect Heart, Brain,

Hylde Zirpoli1, Chuchun L Chang1, Yvon A Carpentier2,3

  • 1Institute of Human Nutrition, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY 10032, USA;

Annual Review of Nutrition
|September 23, 2020
PubMed

Insights

Omega-3 fatty acids (FAs) show promise in treating cardiovascular and central nervous system (CNS) diseases by modulating cell membranes and signaling. Acute and chronic treatments offer distinct protective pathways for heart and brain injuries.

Area of Science:

  • Cardiovascular and Central Nervous System (CNS) Disease Research
  • Molecular Biology and Therapeutics

Background:

  • Omega-3 fatty acids (FAs) are investigated for therapeutic potential in cardiovascular and CNS diseases.
  • Existing research highlights their role in modulating cell membrane fluidity, intracellular signaling, and bioactive mediator production.

Purpose of the Study:

  • To review novel omega-3 FA therapeutic approaches and their molecular mechanisms in cardiovascular and CNS diseases.
  • To compare the differential effects of chronic and acute omega-3 FA treatments on protective pathways.
  • To analyze recent clinical trials and meta-analyses, discussing reasons for controversial results and suggesting improvements for future studies.

Main Methods:

  • Review of in vitro and in vivo research studies on omega-3 FAs.
  • Analysis of randomized clinical trials and meta-analyses concerning omega-3 FA interventions.
  • Comparative assessment of chronic versus acute omega-3 FA treatment strategies.

Main Results:

  • Omega-3 FAs exert synergistic effects through cell membrane modulation, signaling pathway regulation, and bioactive mediator generation.
  • Acute omega-3 FA treatment demonstrates potential for preserving cardiac and neurological functions.
  • Differential pathways are activated by chronic and acute omega-3 FA treatments in heart, brain, and spinal cord injuries.

Conclusions:

  • Acute omega-3 FA administration presents a novel strategy for cardiac and neurological protection.
  • Combined acute and chronic omega-3 FA treatment may offer enhanced therapeutic benefits for cardiovascular and CNS conditions.
  • Optimizing clinical trial design is crucial for clarifying the efficacy of omega-3 FA therapeutics.
Keywords:
acute treatmentchronic treatmentmyocardial infarctionomega-3 fatty acidsspinal cord and brain injurystroke

More Related Videos

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine10:05

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Published on: July 7, 2016

8.7K
Author Spotlight: Establishing a Reliable Distal MCA Occlusion Model in Mice for Stroke Research07:34

Author Spotlight: Establishing a Reliable Distal MCA Occlusion Model in Mice for Stroke Research

Published on: December 15, 2023

2.9K

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
223
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
216
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
2.6K
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
157
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
241
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
405